Clover Health Publishes Q3 2026 Earnings Call Transcript
- Clover Health raised its 2026 net income guidance floor to $25 million, targeting $25 million to $35 million in its first profitable full year.
- The third-quarter earnings call featured CEO Andrew Toy, CFO Clay Thornton and investor relations representative Ryan Schmidt.
- Quarterly revenue rose 53% to $759 million; net income reached $6 million versus a $24 million loss a year earlier.
- Full-year adjusted EBITDA guidance narrowed to $75 million to $85 million, with a seasonal fourth-quarter loss expected.
- Management expects meaningful earnings expansion in 2027 from cohort maturation and operating leverage, alongside another strong year of membership growth.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clover Health Investments Corp. published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.